Company / EPS (Basic)
RxSight, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.41
FY2025
5-year range
-$3.57 / $0.91
FY2021-FY2025
Trend
+41.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.41 to $-1.41 over the past 2 years.
Based on SEC 10-K filings.
-1.41 in FY2025.
Improved from $-2.41 to $-1.41 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 41.5% year-over-year.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.41 | +41.5% |
| FY2024 | -$2.41 | +0.0% |
| FY2023 | -$2.41 | +32.5% |
| FY2022 | -$3.57 | -492.3% |
| FY2021 | $0.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026